JP2020509763A5 - - Google Patents

Download PDF

Info

Publication number
JP2020509763A5
JP2020509763A5 JP2019549562A JP2019549562A JP2020509763A5 JP 2020509763 A5 JP2020509763 A5 JP 2020509763A5 JP 2019549562 A JP2019549562 A JP 2019549562A JP 2019549562 A JP2019549562 A JP 2019549562A JP 2020509763 A5 JP2020509763 A5 JP 2020509763A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid construct
host cell
nucleotide sequence
exogenous nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019549562A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020509763A (ja
JP7177076B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/051572 external-priority patent/WO2018167621A1/en
Publication of JP2020509763A publication Critical patent/JP2020509763A/ja
Publication of JP2020509763A5 publication Critical patent/JP2020509763A5/ja
Application granted granted Critical
Publication of JP7177076B2 publication Critical patent/JP7177076B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019549562A 2017-03-16 2018-03-09 チロシン原栄養性 Active JP7177076B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762472225P 2017-03-16 2017-03-16
US62/472,225 2017-03-16
US201862628018P 2018-02-08 2018-02-08
US62/628,018 2018-02-08
PCT/IB2018/051572 WO2018167621A1 (en) 2017-03-16 2018-03-09 Tyrosine prototrophy

Publications (3)

Publication Number Publication Date
JP2020509763A JP2020509763A (ja) 2020-04-02
JP2020509763A5 true JP2020509763A5 (enExample) 2021-04-08
JP7177076B2 JP7177076B2 (ja) 2022-11-22

Family

ID=61802237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019549562A Active JP7177076B2 (ja) 2017-03-16 2018-03-09 チロシン原栄養性

Country Status (5)

Country Link
US (1) US20200056190A1 (enExample)
EP (1) EP3596206A1 (enExample)
JP (1) JP7177076B2 (enExample)
CA (1) CA3056182A1 (enExample)
WO (1) WO2018167621A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10738334B2 (en) * 2015-09-23 2020-08-11 Pfizer Inc. Cells having reduced BCAT1
US11939601B2 (en) 2017-11-22 2024-03-26 Modernatx, Inc. Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria
BR112020015798A2 (pt) 2018-02-01 2021-03-09 Homology Medicines, Inc. Composições de vírus adeno-associado para restaurar função de gene da pah e métodos de uso das mesmas
CA3133330A1 (en) 2019-03-13 2020-09-17 Generation Bio Co. Non-viral dna vectors and uses thereof for expressing phenylalanine hydroxylase (pah) therapeutics
KR20220097910A (ko) * 2019-11-14 2022-07-08 론자 리미티드 세포 선택 방법
TW202208632A (zh) 2020-05-27 2022-03-01 美商同源醫藥公司 用於恢復pah基因功能的腺相關病毒組成物及其使用方法
US20230235298A1 (en) * 2020-06-01 2023-07-27 Modernatx, Inc. Phenylalanine hydroxylase variants and uses thereof
EP4301861A1 (en) 2021-03-03 2024-01-10 Shape Therapeutics Inc. Auxotrophic cells for virus production and compositions and methods of making

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4713339A (en) * 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
AU2353384A (en) * 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US4754065A (en) 1984-12-18 1988-06-28 Cetus Corporation Precursor to nucleic acid probe
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4777127A (en) 1985-09-30 1988-10-11 Labsystems Oy Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
GB8702816D0 (en) 1987-02-07 1987-03-11 Al Sumidaie A M K Obtaining retrovirus-containing fraction
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
US5166320A (en) 1987-04-22 1992-11-24 University Of Connecticut Carrier system and method for the introduction of genes into mammalian cells
US5422120A (en) 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
AP129A (en) 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
EP0454781B1 (en) 1989-01-23 1998-12-16 Chiron Corporation Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof
DE69034168T3 (de) 1989-03-21 2013-04-11 Vical, Inc. Expression von exogenen Polynukleotidsequenzen in Wirbeltieren
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6291159B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for producing polymers having a preselected activity
EP1645635A3 (en) 1989-08-18 2010-07-07 Oxford Biomedica (UK) Limited Replication defective recombinant retroviruses expressing a palliative
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
CA2067194C (en) 1989-10-05 2003-03-18 Glenn Kawasaki Cell-free synthesis and isolation of novel genes and polypeptides
US6657103B1 (en) 1990-01-12 2003-12-02 Abgenix, Inc. Human antibodies derived from immunized xenomice
NZ237464A (en) 1990-03-21 1995-02-24 Depotech Corp Liposomes with at least two separate chambers encapsulating two separate biologically active substances
GB9021679D0 (en) 1990-10-05 1990-11-21 Gorman Scott David Antibody preparation
DE69233013T2 (de) 1991-08-20 2004-03-04 The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
WO1993010218A1 (en) 1991-11-14 1993-05-27 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Vectors including foreign genes and negative selective markers
GB9125623D0 (en) 1991-12-02 1992-01-29 Dynal As Cell modification
FR2688514A1 (fr) 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
JPH07507689A (ja) 1992-06-08 1995-08-31 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 特定組織のターゲティング方法及び組成物
JPH09507741A (ja) 1992-06-10 1997-08-12 アメリカ合衆国 ヒト血清による不活性化に耐性のあるベクター粒子
GB2269175A (en) 1992-07-31 1994-02-02 Imperial College Retroviral vectors
CA2592997A1 (en) 1992-12-03 1994-06-09 Genzyme Corporation Pseudo-adenovirus vectors
AU6818094A (en) 1993-04-22 1994-11-08 Depotech Corporation Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
JP3532566B2 (ja) 1993-06-24 2004-05-31 エル. グラハム,フランク 遺伝子治療のためのアデノウイルスベクター
EP0694070B1 (en) 1993-09-15 2002-04-10 Chiron Corporation Recombinant alphavirus vectors
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
JP3875990B2 (ja) 1993-10-25 2007-01-31 カンジ,インコーポレイテッド 組換えアデノウイルスベクターおよび使用方法
NZ276305A (en) 1993-11-16 1997-10-24 Depotech Corp Controlled release vesicle compositions
WO1995030763A2 (en) 1994-05-09 1995-11-16 Chiron Viagene, Inc. Retroviral vectors having a reduced recombination rate
WO1996017072A2 (en) 1994-11-30 1996-06-06 Chiron Viagene, Inc. Recombinant alphavirus vectors
AU2998597A (en) 1996-05-06 1997-11-26 Chiron Corporation Crossless retroviral vectors
WO2001068822A2 (en) * 2000-03-14 2001-09-20 Nilab Aps Method of treating phenylketonuria and means therefor
TWI438010B (zh) 2002-05-02 2014-05-21 Wyeth Corp 卡奇黴素(calicheamicin)衍生物-載體共軛物
US9243253B2 (en) * 2009-05-11 2016-01-26 Pfenex, Inc. Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein
WO2012027533A1 (en) 2010-08-25 2012-03-01 Gt Life Sciences, Inc. Selectable markers and related methods
WO2012145682A1 (en) 2011-04-21 2012-10-26 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
DK3489366T3 (da) * 2011-06-01 2020-02-24 Prec Biosciences Inc Fremgangsmåder og produkter til produktion af manipulerede mammale cellelinier med forstærkede transgener
EP2711428A1 (en) 2012-09-21 2014-03-26 Lonza Biologics plc. Site-specific integration
WO2015032911A1 (en) * 2013-09-05 2015-03-12 Danmarks Tekniske Universitet Microorganisms for efficient production of melatonin and related compounds
BR112016028564A2 (pt) * 2014-06-06 2018-01-30 Regeneron Pharma método para modificar um locus-alvo em uma célula.
US10738334B2 (en) * 2015-09-23 2020-08-11 Pfizer Inc. Cells having reduced BCAT1

Similar Documents

Publication Publication Date Title
JP2020509763A5 (enExample)
CN107435051B (zh) 一种通过CRISPR/Cas9系统快速获得大片段缺失的细胞系基因敲除方法
JP7103603B2 (ja) Ch3ドメインに基づくヘテロダイマー分子、その調製方法及び用途
JP2018518957A5 (enExample)
JP2014012014A (ja) 宿主細胞中の組換えタンパク質の発現を増進するための組換え発現ベクター要素(rEVE)
JP2011504721A5 (enExample)
CN102703424B (zh) 一种重组工程介导的大肠杆菌基因组点突变的方法
CN108424907A (zh) 一种高通量dna多位点精确碱基突变方法
RU2007124369A (ru) Производство белков
EP3159411B1 (en) Vector comprising gene fragment for enhancement of recombinant protein expression and use thereof
US9752159B2 (en) Stable expression system for eukaryotic cells
RU2013123638A (ru) Рекомбинантная плазмидная днк, кодирующая химерное антитело против фактора некроза опухоли-альфа человека, линия эукариотических клеток - продуцент химерного антитела и способ получения химерного антитела
US11136598B2 (en) Method for cell line development
CN103060367A (zh) 一种离体高效构建多拷贝乳酸克鲁维酵母表达载体的方法
CN114774421A (zh) 运动发酵单胞菌内源性启动子突变体
CN115595329A (zh) 一种用于蛋白质合成的表达序列的构建方法
WO2025141778A1 (ja) 新規プロモーター
CN104404069A (zh) 一种低拷贝pTerm质粒及其构建方法和应用
CN104120119B (zh) 一种3-脱氢奎尼酸合成酶突变体及其基因和应用
WO2025177984A1 (ja) 二本鎖環状dnaベクター
CN1657628A (zh) 一种高效筛选目的蛋白的表达载体,其制备方法及用途
CN117683804A (zh) 一种核酸构建物以及在ivtt体系中的应用
CN109153985A (zh) 转化体、以及转铁蛋白的制造方法
CN116555261A (zh) 一种乳酸片球菌启动子文库及其构建方法和应用
KR102010246B1 (ko) 미세조류 에틀리아 유래의 프로모터 및 이의 용도